GAD2 and aceruloplasminemia: GAD65 antibodies are described in children presenting well-known clinical disorders such as stiff-person syndrome, temporal lobe epilepsy or cerebellar ataxia, but much less is known about their occurrence in pediatric psychiatric syndromes.